Intensity Therapeutics INTS
NASDAQ INTS
$3.14 -0.14 (-4.14%)
As of: Oct 21, 2026 · 3:44 PM EDT

Intensity Therapeutics (INTS) Net Shares Issued and Repurchased (2023 - 2026)

Updated

Analysis

Intensity Therapeutics (INTS) Net Shares Issued and Repurchased (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 138.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -346.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Intensity Therapeutics 8.51 Mn -30.26 Mn - -157,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -157,000.00
Mar 31, 2026 157,000.00
Dec 31, 2025 56,000.00
Jun 30, 2025 4.31 Mn
Mar 31, 2025 345,000.00
Dec 31, 2024 47,000.00
Sep 30, 2024 263,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 8,000.00
Sep 30, 2023 20.52 Mn
API Access

Intensity Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=INTS&period=max&api_key=YOUR_API_KEY